Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status - PubMed (original) (raw)
. 2002 Sep 1;101(1):23-31.
doi: 10.1002/ijc.10565.
Affiliations
- PMID: 12209584
- DOI: 10.1002/ijc.10565
Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status
Roberta Magrini et al. Int J Cancer. 2002.
Abstract
Irinotecan (CPT-11), a recently introduced component of a standard chemotherapy for colorectal cancer, induces in colon cancer cell lines in vitro cell cycle arrest and apoptosis. Since sporadic colon carcinomas exhibit in 50-60% mutations in the p53 gene and in 10-15% an MSI phenotype due in the great majority of the cases to hMLH1 inactivation, we investigated how these lesions influence the cellular effects of CPT-11 by using colorectal carcinoma cell line HCT116 (which has the genotype p53(+/+),hMLH1(-)) and 2 derivative cell lines with the genotypes p53(+/+),hMLH1(+) and p53(-/-),hMLH1(-). CPT-11 treatment induced G2/M arrest in all 3 cell lines within 48 hr. In the p53(+/+),hMLH1(+) cell line, G2/M arrest was maintained for at least 12 days. There was little concomitant apoptosis, but this was enhanced when the hMLH1 protein was absent. This enhanced apoptosis was accompanied by a shorter duration of the G2/M arrest than in the hMLH1(+) cell line. Partial abrogation of G2/M arrest by caffeine enhanced apoptosis in both hMLH1(+) and hMLH1(-) cells. By contrast, in the p53(-/-) cell line, the G2/M arrest was terminated within 4 days. Termination of the G2/M arrest was accompanied by a high level of apoptosis detectable through poly(ADP-ribose)polymerase (PARP) cleavage, DNA fragmentation and by the appearance of cells with a DNA content <2N. The triggering of G2/M arrest was accompanied in the 3 cell lines by a transient phosphorylation of cdc-2, while the maintenance of the arrest in the p53(+/+) cell lines was accompanied by the overexpression of p53 and p21 proteins and, consequently, by the inhibition of cdc-2 kinase activity. These data indicate that: (i) CPT-11 induces long-term arrest in p53(+/+) cells and a short-term arrest followed by apoptosis in p53(-/-) cells; (ii) triggering of the arrest is p53 independent and is associated with a brief increase of phosphorylation of cdc-2, while the p53-dependent maintenance of G2/M arrest is associated with the inhibition of cdc-2 kinase activity by p21; and (iii) lack of hMLH1 protein enhances CPT-11-induced apoptosis. These results may be useful for designing rational therapies dependent on the p53 and mismatch-repair status in the tumor.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
- Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
Vikhanskaya F, Colella G, Valenti M, Parodi S, D'Incalci M, Broggini M. Vikhanskaya F, et al. Clin Cancer Res. 1999 Apr;5(4):937-41. Clin Cancer Res. 1999. PMID: 10213232 - Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
Hapke G, Yin MB, Wu J, Frank C, Rustum YM. Hapke G, et al. Int J Oncol. 2002 Nov;21(5):1059-66. Int J Oncol. 2002. PMID: 12370755 - Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications.
Butler LM, Hewett PJ, Fitridge RA, Cowled PA. Butler LM, et al. Aust N Z J Surg. 1999 Feb;69(2):88-94. doi: 10.1046/j.1440-1622.1999.01498.x. Aust N Z J Surg. 1999. PMID: 10030808 Review. - Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
Harris CC. Harris CC. J Natl Cancer Inst. 1996 Oct 16;88(20):1442-55. doi: 10.1093/jnci/88.20.1442. J Natl Cancer Inst. 1996. PMID: 8841019 Review.
Cited by
- Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
Sato M, Mizuta K, Han Q, Morinaga S, Kang BM, Kubota Y, Mori R, Baranov A, Kobayashi K, Ardjmand D, Kobayashi N, Bouvet M, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. In Vivo. 2024 May-Jun;38(3):1058-1063. doi: 10.21873/invivo.13539. In Vivo. 2024. PMID: 38688611 Free PMC article. - Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer.
Wilkinson K, Ng W, Roberts TL, Becker TM, Lim SH, Chua W, Lee CS. Wilkinson K, et al. J Clin Pathol. 2021 Oct;74(10):625-634. doi: 10.1136/jclinpath-2020-207309. Epub 2021 Mar 22. J Clin Pathol. 2021. PMID: 33753562 Free PMC article. Review. - Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.
Fountzilas E, Kotoula V, Pentheroudakis G, Manousou K, Polychronidou G, Vrettou E, Poulios C, Papadopoulou E, Raptou G, Pectasides E, Karayannopoulou G, Chrisafi S, Papakostas P, Makatsoris T, Varthalitis I, Psyrri A, Samantas E, Bobos M, Christodoulou C, Papadimitriou C, Nasioulas G, Pectasides D, Fountzilas G. Fountzilas E, et al. ESMO Open. 2019 Mar 12;4(2):e000474. doi: 10.1136/esmoopen-2018-000474. eCollection 2019. ESMO Open. 2019. PMID: 31231557 Free PMC article. - Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy.
Al-Keilani MS, Alsmadi DH, Darweesh RS, Alzoubi KH. Al-Keilani MS, et al. Clin Pharmacol. 2018 Mar 5;10:23-29. doi: 10.2147/CPAA.S153780. eCollection 2018. Clin Pharmacol. 2018. PMID: 29551915 Free PMC article. - Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.
Zhang CM, Lv JF, Gong L, Yu LY, Chen XP, Zhou HH, Fan L. Zhang CM, et al. Int J Environ Res Public Health. 2016 Sep 8;13(9):892. doi: 10.3390/ijerph13090892. Int J Environ Res Public Health. 2016. PMID: 27618077 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous